Webinar: From Utah the U.K.—Why Companies Should Consider an IPO on the London Stock Exchange
May 14, 2021
On May 12, 2021, BioUtah presented a webinar featuring representatives of the banking firm, Stifel, as well as James McCullough, CEO of Renalytix, a Utah based company. The webinar presented the opportunity for Utah companies to raise capital through an offering on London Stock Exchange’s AIM platform. Renalytix is one of the most successful companies in years to do just that skipping the traditional process of raising early stage and venture capital.
If you did not have the opportunity to tune in, you can click on the link below to watch the full one hour webinar. It is a unique opportunity for raising capital.
Recent News
- BioUtah’s 2026 Utah Life Sciences Summit Recap
- 2026 Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit
- PROGRESS TRIAL DEMONSTRATES EDWARDS TAVR IS SUPERIOR TO CLINICAL SURVEILLANCE FOR MODERATE AS PATIENTS WITH AT-RISK FEATURES
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
- Utah Business, Government Leaders Deepen Connections in Ireland
- Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test
